SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding SpringWorks Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 142 | 1 | 144 | +3 |
| Shares | 45.1M | 167.2K | 45.5M | +540.5K (+1.2%) |
| Value | $2.86B | $10.6M | $2.82B | −$32.8M (−1.2%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Janus Henderson Group PLC | 78,109 | $4.85M | 0.00% |
| CWM, LLC | 49,273 | $3.05M | 0.02% |
| Toronto Dominion Bank | 23,882 | $1.48M | 0.00% |
| Brinker Capital Investments, LLC | 21,112 | $1.31M | 0.02% |
| Allspring Global Investments Holdings, LLC | 14,457 | $896.0K | 0.00% |
| Pendal Group Limited | 13,354 | $828.0K | 0.01% |
| Brown Advisory Inc | 5,902 | $366.0K | 0.00% |
| Virtu Financial LLC | 5,632 | $349.0K | 0.04% |
| XTX Topco Ltd | 4,736 | $294.0K | 0.17% |
| Laurel Wealth Advisors, Inc. | 4,032 | $250.0K | 0.02% |
| Guggenheim Capital LLC | 3,334 | $207.0K | 0.00% |
| High Net Worth Advisory Group LLC | 1,000 | $62.0K | 0.02% |
| Parallel Advisors, LLC | 763 | $47.0K | 0.00% |
| Leonteq Securities AG | 300 | $18.6K | 0.00% |
| Dark Forest Capital Management LP | 254 | $16.0K | 0.01% |
| Captrust Financial Advisors | 159 | $10.0K | 0.00% |
| Spire Wealth Management | 25 | $2.00K | 0.00% |
| Confluence Wealth Services, Inc. | 46 | $2.00K | 0.00% |
| Covestor Ltd | 8 | $1.00K | 0.00% |
Sold out (16)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Jennison Associates LLC | 645,521 | $41.0M |
| Consonance Capital Management LP | 305,994 | $19.4M |
| CIBC Asset Management Inc | 196,912 | $12.5M |
| Caas Capital Management LP | 112,643 | $7.15M |
| Castleark Management LLC | 89,086 | $5.65M |
| CastleArk Alternatives, LLC | 89,086 | $5.65M |
| Monashee Investment Management LLC | 56,766 | $3.60M |
| Prudential Financial Inc | 53,610 | $3.40M |
| Natixis | 33,400 | $2.12M |
| AQR Capital Management LLC | 7,258 | $460.0K |
| Bank of Montreal | 6,507 | $450.0K |
| Meeder Asset Management Inc | 1,255 | $80.0K |
| Penserra Capital Management LLC | 1,130 | $71.0K |
| O'Shaughnessy Asset Management, LLC | 797 | $51.0K |
| Red Tortoise LLC | 49 | $1.00K |
| Bell Investment Advisors, Inc | 6 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 167,171 | $10.6M |